Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
algorithm
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, incidence
Alzheimer's disease, prognosis of
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
anticoagulant, treatment
antiphospholipid antibodies
apolipoprotein E
biologic markers
carcinoma
CAT scan
CAT scan, abnormal
CAT scan, emission, abnormal
CAT scan, venography
cerebral edema, vasogenic
cerebral infarction
cerebral venous infarction
cerebral venous thrombosis
cerebral venous thrombosis, deep
cerebral venous thrombosis, etiology
cerebral venous thrombosis, recurrent
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, prevention of
cerebrovascular accident, thrombolytic agents in treatment
children
complications
craniectomy, decompressive
D-dimer
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, clinical diagnosis
dementia, diagnostic classification
dementia, differential diagnosis of
dementia, incidence
dementia, prevalence of
dementia, prevention of
dementia, treatment of
diabetes mellitus
dural sinus thrombosis
educational status
endovascular therapy
epidemiology of neurology
evidence-based research
Factor V Leiden
fibrinolytic agents
fibrinolytic agents, intra-venous local infusion
gadolinium
gene
genetic neurologic disorders
headache
hydrocephalus
incidence
interobserver agreement
intracranial pressure, increased
inverse association
leisure activity
level of consciousness, decreased
lifestyle
Mini Mental Status Examination
misdiagnosis
mortality
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, contrast enhanced
MRI, venography
neurologic complications of, systemic disease
neurologic disease, diagnoses of
neurologic examination, focal
neuroprotective agents
old age, neurology of
oral contraceptives
pitfalls
practice guidelines
pregnancy, neurologic complications in
prethrombotic state
prevention of neurologic disorders
prognosis
protein C deficiency
protein S deficiency
psychological testing
review article
rhinorrhea, CSF
risk factors
seizure
sodium-glucoe cotransporter-2 inhibitors
tau protein
tissue plasminogen activator, intravenous
treatment of neurologic disorder
workup
Showing articles 150 to 200 of 910 << Previous Next >>

Serial MRI and CSF Biomarkers in Normal Aging, MCI, and AD
Neurol 75:143-151, Vemuri,P., et al, 2010

Incidence of Cerebral Microbleeds: A Longitudinal Study in Memory Clinic Population
Neurol 74:1954-1960, Goos,J.D.C., et al, 2010

Early Alzheimers Disease
NEJM 362:2194-2201, Mayeux,R., 2010

Dysexecutive Syndrome: Diagnostic Criteria and Validation Study
Ann Neurol 68:855-864, Godefroy,O.,et al, 2010

Fully-Automated Quantification of Regional Brain Volumes for Improved Detection of Focal Atrophy in Alzheimers Disease
AJNR 30:578-580, Brewer, J.B.,et al, 2009

Predictors of Driving Safety in Early Alzheimer Disease
Neurol 72:521-527, Dawson,J.D.,et al, 2009

Rapidly Progressive Neurodegenerative Dementias
Arch Neurol 66:201-207, Josephs,K.A.,et al, 2009

Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009

Alzheimers Disease
BMJ 338:467-471, Burns,A. &Iliffe,S., 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Incidence and Mortality Rates of Myasthenia Gravis and Myasthenic Crisis in US Hospitals
Neurol 72:1548-1554, Alshekhlee,A.,et al, 2009

Donepezil Treatment of Patients with MCI: A 48-Week Randomized, Placebo-Controlled Trial
Neurol 72:1555-1561, Doody,R.S.,et al, 2009

Long-Term Effects of the Concomitant Use of Memantine with Cholinesterase Inhibition in Alzheimer Disease
JNNP 80:600-607, Lopez,O.L.,et al, 2009

Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009

Age, Neuropathology, and Dementia
NEJM 360:2302-2309, Savva,G.M.,et al, 2009

Differential Diagnosis of Postpartum Headaches
Rev Mex Anest 32:Suppl1 S16-S23, MacArthur,A., 2009

CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009

Association Between Mid-Life Martial Status and Cognitive Function in Later Life: Population Based Cohort Study
BMJ 339:99,57, H�kansson,K.,et al, 2009

Disclosure of APOE Genotype for Risk of Alzheimers Disease
NEJM 361:245-254,298, Green,R.C.,et al, 2009

Positron Emission Tomography in Diagnosis of Visual Variant Alzheimer Disease
J Neuro-Ophthalmol 29:149-150, Finelli,P.F., 2009

Risk of Dementia and AD with Prior Exposure to NSAIDs in an Elderly Community-Based Cohort
Neurol 72:1899-1905,1884, Breitner,J.C.S.,et al, 2009

Seizures in Alzheimer Disease: Who, When, and How Common?
Arch Neurol 66:992-997, Scarmeas,N.,et al, 2009

The Clinical Course of Advanced Dementia
NEJM 361:1529-1538, 1595, Mitchell,S.,et al, 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

Akinetopsia in the Posterior Cortical Variant of Alzheimer Disease
Neurol 73:731-732, Tsai,P. &Mendez,M.F., 2009

DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009

Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging
JAMA 302:2565-2572, 2593, Lieb,W.,et al, 2009

Association of Parental Dementia With Cognitive and Brain MRI Measures in Middle-Aged Adults
Neurol 73:2071-2078, 2054, Debette,S.,et al, 2009

Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009

Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA
Stroke 40:3834-3840, Smith,W.,et al, 2009

Clinical Syndromes Associated with Posterior Atrophy: Early Age at Onset AD Spectrum
Neurol 73:1571-1578, Migliaccio,R.,et al, 2009

CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009

Predicting the Time of Conversion to MCI in the Elderly: Role of Verbal Expression and Learning
Neurol 73:1436-1442, 1432, Oulhaj,A.,et al, 2009

Foreign Accent Syndrome as the Initial Sign of Primary Progressive Aphasia
JNNP 79:79-81, Luzzi,S.,et al, 2008

Risperidone, Haloperidol, and Placebo in the Treatment of Aggressive Challenging Behaviour in Patients With Intellectual Disability: A Randomised Controlled Trial
Lancet 371:57-63,9, Tyrer,P.,et al, 2008

NSAID Use and Dementia Risk in the Cardiovascular Health Study: Role of APOE and NSAID Type
Neurol 70:17-24, Szekely,C.A.,et al, 2008

Joint Effect of Stroke and APOE 4 on Dementia Risk: The Canadian Study of Health and Aging
Neurol 70:9-16,5, Jin,Y.P.,et al, 2008

Survival Times in People with Dementia: Analysis From Population Based Cohort Study With 14 Year Follow-Up
BMJ 336:258-262,225, Xie,J.,et al, 2008

A longitudinal Study of Drivers With Alzheimer Disease
Neurol 70:1171-1178, Ott, B.R.,et al, 2008

Conjugal Alzheimer Disease: Risk in Children When Both Parents Have Alzheimer Disease
Arch Neurol 65:373-378, Jayadev,S.,et al, 2008

Safety and Efficacy of Galantamine in Subjects with Mild Cognitive Impairment
Neurol 70:2024-2035, Winblad,B.,et al, 2008

Disease-Modifying Therapies for Alzheimers: New Drugs on the Horizon
Practical Neurology 7:16-23, Christensen,D.B., 2008

Biochemical Markers in Persons With Preclinical Familial Alzheimer Disease
Neurol 71:85-92,78, Ringman,J.M.,et al., 2008

Phase 2 Safety Trial Targeting Amyloid � Production With a ?-Secretase Inhibitor in Alzheimer Disease
Arch Neurol 65:1031-1038, Fleisher,A.S.,et al., 2008

Long-Term Effects of A�42 Immunisation in Alzheimers Disease: Follow-Up of a Randomised, Placebo-Controlled Phase I Trial
Lancet 372:216-223,180, Holmes,C.,et al., 2008

Rapidly Progressive Dementia
Ann Neurol 64:97-108, Geschwind,M.D.,et al., 2008

Effect of Demebon on Cognition, Activities of Daily Living, Behavior, and Global Function in Patients With Mild-To-Moderate Alzheimers Disease: A Randomised, Double-Blind, Placebo-Controlled Study
Lancet 372:207-215,179, Doody, R.S.,et al., 2008

The Logopenic/Phonological Variant of Primary Progressive Aphasia
Neurol 71:1227-1234, Gorno-Tempini,M.L.,et al, 2008

Assessment of �-Amyloid in a Frontal Cortical Brain Biopsy Specimen and by Positron Emission Tomography with Carbon 11-Labeled Pittsburgh Compound B
Arch Neurol 65:1304-1309,1281, Leinonen,V.,et al, 2008

A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008



Showing articles 150 to 200 of 910 << Previous Next >>